Wang and his colleagues verified that m6A “reader” IGF2BP3 recognized and bound m6A sites on METTL3-mediated HDGF mRNA to stabilize it and the subsequent GC angiogenesis and malignant progress (142). The gene discussed is IGF2BP3; the disease is gastric cancer.